论文部分内容阅读
目的 探讨血液透析联合血液灌流治疗尿毒症伴顽固性高血压患者的临床效果?方法选择本溪市第六人民医院收治的42例尿毒症患者伴顽固性高血压患者纳入研究对象，时间为2018年4月至2019年3月，依据治疗方式的不同，将其分为对照组(n=21，采取血液透析治疗)和研究组(n=21，采取血液透析联合血液灌流治疗)，对比两组治疗效果及预后情况?结果 治疗有效率方面，研究组患者治疗总有效率为95.24%?对照组患者治疗总有效率为71.43%(P 0.05)，研究“,”Objective To investigate the clinical effects of hemodialysis combined with blood perfusion in the treatment of uremic patients with refractory hypertension. Methods A total of 42 patients with uremia and intractable hypertension who were admitted to our hospital from April 2018 to March 2019 were selected as the research objects. According to the different treatment methods， they were divided into a control group and an observation group， with 21 cases in each group. The control group was treated with hemodialysis， and the study group was treated with hemodialysis combined with hemoperfusion to compare the treatment effects and prognosis of the two groups. Results In terms of treatment effciency， the total effective rate of treatment in the study group was 95.24%， and the total effective rate in the control group was 71.43% (P0.05). The improvement of physiological indexes and blood pressure in the study group after treatment was better than that of the control group (P0.05). After treatment， the quality of life of the observation group was better than that of the control group (P<0.05). Conclusion For patients with uremia accompanied by intractable hypertension， the combination of hemodialysis treatment and hemoperfusion can signi?cantly improve the clinical treatment effciency of the patients， and at the same time， the physiological indicators of the patients are well controlled， and the patient\'s physiology can be effectively improved. The quality of life has broad clinical application value.